Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1998
03/04/1998EP0825989A1 Substituted oxazoles for the treatment of inflammation
03/04/1998EP0825981A1 Novel heterocyclic compounds
03/04/1998EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
03/04/1998EP0825872A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
03/04/1998EP0825867A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
03/04/1998EP0692962B1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
03/04/1998EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
03/04/1998CN1175262A Novel receptor
03/04/1998CN1175256A Tetracyclic spiro compounds, process for their preparation and their use as 5 HT1D receptor antagonists
03/04/1998CN1175253A Piperazine 2, 5 dione derivatives as modulators of multi-drug resistance
03/04/1998CN1175252A Imidazole derivatives as protein kinase inhibitors in particular egf-rthyrosine kinase
03/04/1998CN1175246A Substituted azetidin-2-ones for treatment of atherosclerosis
03/04/1998CN1175210A 4,4-(disubstituted) cyclohexan-1-ols and related compounds
03/04/1998CN1175209A 3, 3 -(disubstituted) cyclohexan -1 -ols monomers and related compounds
03/04/1998CN1174845A Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
03/04/1998CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
03/04/1998CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it
03/03/1998US5723681 3,3-(disubstituted)cyclohexan-1-01 dimers and related compounds
03/03/1998US5723608 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
03/03/1998US5723607 Chemical intermediates, enzyme inhibitors, antitumor agents, antigrowth agents
03/03/1998US5723589 Nonglycoside linkage
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723495 Benzamidoxime prodrugs as antipneumocystic agents
03/03/1998US5723492 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
03/03/1998US5723490 THF-containing sulfonamide inhibitors of aspartyl protease
03/03/1998US5723489 Aryloxypropanolamine beta 3 adrenergic agonists
03/03/1998US5723485 Analgesic, antiinflammatory agents
03/03/1998US5723484 Benzopyran compounds as 5-HT2C receptor antagonists
03/03/1998US5723483 Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them
03/03/1998US5723482 Active compounds and cosmetic and dermatological formulations
03/03/1998US5723480 Adhesion receptor antagonists III
03/03/1998US5723472 Aminobenzoic acid derivatives
03/03/1998US5723465 Inhibitors for cell adhesion and cellular infiltration
03/03/1998US5723464 Piperazine derivatives
03/03/1998US5723463 Pyrido 3,2-E!pyrazinones with anti-asthmatic action and processes for their manufacture
03/03/1998US5723460 Potent and selective phosphodiesterase type iv inhibitors; useful in the prophylaxis and treatment of disease such as asthma where unwanted inflammatory response or muscular spasm is present
03/03/1998US5723456 Therapeutic treatment for cardiovascular diseases
03/03/1998US5723449 Antisecretory agents and anticarcinogenic agents
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723442 Peptide derivatives
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723146 Pharmaceutical preparations
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4
03/02/1998CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf
02/1998
02/28/1998CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007853A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007840A1 Novel dnas and process for producing proteins by using the same
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007754A1 T1 receptor-like ligand ii
02/26/1998WO1998007736A1 Don-1 gene and polypeptides and uses therefor
02/26/1998WO1998007726A1 Substituted pyrrolopyrimidines and processes for their preparation
02/26/1998WO1998007725A1 Purine derivatives and their use as anti-coagulants
02/26/1998WO1998007723A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/26/1998WO1998007715A1 Novel benzofuran-4-carboxamides
02/26/1998WO1998007714A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor
02/26/1998WO1998007713A1 High molecular weight polymer-based prodrugs
02/26/1998WO1998007711A1 Troponyl piperazines as selective dopamine d4 receptor ligands
02/26/1998WO1998007704A1 Tetrahydroquinoline derivatives as eaa antagonists
02/26/1998WO1998007695A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
02/26/1998WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
02/26/1998WO1998007692A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
02/26/1998WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
02/26/1998WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions
02/26/1998WO1998007427A1 Cocaine receptor binding ligands
02/26/1998WO1998007420A1 Neuropeptide-y ligands
02/26/1998WO1998007417A1 Pharmaceutical composition comprising coenzyme q¿10?
02/26/1998WO1998007321A1 Method for inhibiting the expression of fas
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997038966A3 Cytoprotective compounds
02/26/1998CA2268051A1 Neuropeptide-y ligands
02/26/1998CA2264220A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2264178A1 Method for inhibiting the expression of fas
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2264000A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor
02/26/1998CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998CA2263875A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263854A1 Don-1 gene and polypeptides and uses therefor
02/26/1998CA2263832A1 T1 receptor-like ligand ii
02/26/1998CA2263830A1 T1 receptor-like ligand i
02/26/1998CA2263192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2262876A1 Purine derivatives and their use as anti-coagulants
02/26/1998CA2261908A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/26/1998CA2259515A1 Troponyl piperazines as selective dopamine d4 receptor ligands
02/26/1998CA2235148A1 Novel dnas and process for producing proteins by using the same
02/25/1998EP0825260A2 Arginase II
02/25/1998EP0825193A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
02/25/1998EP0825191A2 Chromanyl-ascorbic acid derivatives, their preparation and use
02/25/1998EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use
02/25/1998EP0824545A1 Peptide compositions with growth factor-like activity
02/25/1998EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
02/25/1998EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
1 ... 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 ... 1564